Adele GulfoChief of Commercial Development at Roivant Sciences
Adele Gulfo serves as Chief of Commercial Development at Roivant Sciences. Previously she was Chief Strategy Officer, EVP and Head of Global Commercial Development at Mylan. She also served as President & GM of Pfizer's U.S. Primary Care business unit,which included Commercial Operations and the Managed Markets organization for all of Pfizer's Biopharmaceutical business units.Under her leadership, Pfizer's U.S. Primary Care business generated more than $13 billion in revenue. Earlier in her career at Pfizer, Gulfo was instrumental in the launch and commercial success of LIPITOR, which became the world's best-selling medicine with peak revenues greater than $10B globally. In addition, Gulfo served as President of Latin America in Pfizer's Emerging Markets business unit. Trained as a scientist with experience in both operational and strategic roles, Gulfo serves as an advisor for Cleveland Clinic’s Innovation Center, Partners Healthcare and Springboard Life Sciences. She was recognized for work in developing medical and public-education campaigns that helped to establish the significance of lowering LDL cholesterol in preventing and managing heart disease, and has five patents. She serves on the Board of Directors for Volunteers of America and the Committee of 200 (C200),an invitation-only membership organization of the world’s most successful women business leaders.